<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37273451</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Neutrophil-Derived IL-6 Potentially Drives Ferroptosis Resistance in B Cells in Lupus Kidney.</ArticleTitle><Pagination><StartPage>9810733</StartPage><MedlinePgn>9810733</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9810733</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2023/9810733</ELocationID><Abstract><AbstractText>Ferroptosis resistance is vital for B cell development, especially in inflammatory diseases, yet the underlying mechanism is still unclear. In this study, based on the scRNA-seq technique and flow cytometry, we discovered a proportion of neutrophils exhibited upregulated expression of the IL-6 and correlated with the expression of IL-6 receptor and SLC7A11 from B cells in lupus kidney. Moreover, we identified that in lupus kidney, neutrophils could provide IL-6 to facilitate ferroptosis resistance in B cells via SLC7A11, and inhibition of SLC7A11 could significantly enhance ferroptosis in B cells and could decrease B cell proliferation. This study helps understand the crosstalk between neutrophils and B cells in the kidney in the development of lupus.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zechen Wang et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zechen</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-7412-4637</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jiajia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9186-321X</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Kun</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0006-8209-1090</Identifier><AffiliationInfo><Affiliation>Department of Renal Diseases, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jingjie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1582-2053</Identifier><AffiliationInfo><Affiliation>Life Science and Clinical Research Center, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shaoang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9259-2485</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3308-4143</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yujuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2909-0121</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Lingzhang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-4536-8709</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences, Nanning, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0009-4170-9773</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Renal Diseases, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2459-7046</Identifier><AffiliationInfo><Affiliation>Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise, Guangxi Province, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences, Nanning, Guangxi Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="Y">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>13</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37273451</ArticleId><ArticleId IdType="pmc">PMC10239302</ArticleId><ArticleId IdType="doi">10.1155/2023/9810733</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xin S., Mueller C., Pfeiffer S., et al. MS4A15 drives ferroptosis resistance through calcium-restricted lipid remodeling. Cell Death and Differentiation . 2022;29(3):670&#x2013;686. doi: 10.1038/s41418-021-00883-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00883-z</ArticleId><ArticleId IdType="pmc">PMC8901757</ArticleId><ArticleId IdType="pubmed">34663908</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown C. W., Mercurio A. M. Ferroptosis resistance mediated by exosomal release of iron. Molecular &amp; Cellular Oncology . 2020;7(3, article 1730144) doi: 10.1080/23723556.2020.1730144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2020.1730144</ArticleId><ArticleId IdType="pmc">PMC7199748</ArticleId><ArticleId IdType="pubmed">32391424</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong Q., Qin W., Li Z. H., et al. SLC12A5 Promotes Hepatocellular Carcinoma Growth and Ferroptosis Resistance by Inducing ER Stress and Cystine Transport Changes. Cancer Medicine . 2023;12(7):8526&#x2013;8541. doi: 10.1002/cam4.5605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.5605</ArticleId><ArticleId IdType="pmc">PMC10134347</ArticleId><ArticleId IdType="pubmed">36645171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Kang R., Kroemer G., Tang D. Organelle-specific regulation of ferroptosis. Cell Death and Differentiation . 2021;28(10):2843&#x2013;2856. doi: 10.1038/s41418-021-00859-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00859-z</ArticleId><ArticleId IdType="pmc">PMC8481335</ArticleId><ArticleId IdType="pubmed">34465893</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap D., Chan T. M. B cell abnormalities in systemic lupus erythematosus and lupus nephritis-role in pathogenesis and effect of immunosuppressive treatments. International Journal of Molecular Sciences . 2019;20(24):p. 6231. doi: 10.3390/ijms20246231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20246231</ArticleId><ArticleId IdType="pmc">PMC6940927</ArticleId><ArticleId IdType="pubmed">31835612</ArticleId></ArticleIdList></Reference><Reference><Citation>Canny S. P., Jackson S. W. B cells in systemic lupus erythematosus: from disease mechanisms to targeted therapies. Rheumatic Diseases Clinics of North America . 2021;47(3):395&#x2013;413. doi: 10.1016/j.rdc.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8357318</ArticleId><ArticleId IdType="pubmed">34215370</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Q., Zhang X. From blood to tissue: take a deeper look at B cells in lupus. Cellular &amp; Molecular Immunology . 2021;18(8):2073&#x2013;2074. doi: 10.1038/s41423-021-00713-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00713-9</ArticleId><ArticleId IdType="pmc">PMC8322426</ArticleId><ArticleId IdType="pubmed">34117369</ArticleId></ArticleIdList></Reference><Reference><Citation>Delahaye M. C., Salem K. I., Pelletier J., Aurrand-Lions M., Mancini S. Toward therapeutic targeting of bone marrow leukemic niche protective signals in B-cell acute lymphoblastic leukemia. Frontiers in Oncology . 2021;10, article 606540</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820772</ArticleId><ArticleId IdType="pubmed">33489914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zehentmeier S., Pereira J. P. Cell circuits and niches controlling B cell development. Immunological Reviews . 2019;289(1):142&#x2013;157. doi: 10.1111/imr.12749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12749</ArticleId><ArticleId IdType="pmc">PMC6464388</ArticleId><ArticleId IdType="pubmed">30977190</ArticleId></ArticleIdList></Reference><Reference><Citation>Puga I., Cols M., Barra C. M., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nature Immunology . 2011;13(2):170&#x2013;180. doi: 10.1038/ni.2194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2194</ArticleId><ArticleId IdType="pmc">PMC3262910</ArticleId><ArticleId IdType="pubmed">22197976</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordon Y. Neutrophils zone in to help B cells. Nature Reviews Immunology . 2012;12(2):p. 73. doi: 10.1038/nri3159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3159</ArticleId><ArticleId IdType="pubmed">22266690</ArticleId></ArticleIdList></Reference><Reference><Citation>Chorny A., Casas-Recasens S., Sintes J., et al. The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. The Journal of Experimental Medicine . 2016;213(10):2167&#x2013;2185. doi: 10.1084/jem.20150282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20150282</ArticleId><ArticleId IdType="pmc">PMC5030794</ArticleId><ArticleId IdType="pubmed">27621420</ArticleId></ArticleIdList></Reference><Reference><Citation>Pylaeva E., Ozel I., Squire A., et al. B-helper neutrophils in regional lymph nodes correlate with improved prognosis in patients with head and neck cancer. Cancers . 2021;13(12):p. 3092. doi: 10.3390/cancers13123092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13123092</ArticleId><ArticleId IdType="pmc">PMC8234083</ArticleId><ArticleId IdType="pubmed">34205654</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J. J., Goldstein L., Chen Y. J., et al. Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury. Journal of the American Society of Nephrology . 2020;31(10):2341&#x2013;2354. doi: 10.1681/ASN.2020020220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020020220</ArticleId><ArticleId IdType="pmc">PMC7609001</ArticleId><ArticleId IdType="pubmed">32651223</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S., Zhuang H., Arja R. D., Reeves W. H. A novel monocyte differentiation pattern in pristane-induced lupus with diffuse alveolar hemorrhage. eLife . 2022;11 doi: 10.7554/eLife.76205.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.76205</ArticleId><ArticleId IdType="pmc">PMC9584606</ArticleId><ArticleId IdType="pubmed">36264674</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Jin S., Zhang Z., Ma H., Yang X. Interleukin-6 facilitates tumor progression by inducing ferroptosis resistance in head and neck squamous cell carcinoma. Cancer Letters . 2022;527:28&#x2013;40. doi: 10.1016/j.canlet.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2021.12.011</ArticleId><ArticleId IdType="pubmed">34902522</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S., Guerrero-Juarez C. F., Zhang L., et al. Inference and analysis of cell-cell communication using CellChat. Nature Communications . 2021;12(1):p. 1088. doi: 10.1038/s41467-021-21246-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21246-9</ArticleId><ArticleId IdType="pmc">PMC7889871</ArticleId><ArticleId IdType="pubmed">33597522</ArticleId></ArticleIdList></Reference><Reference><Citation>Criscuolo D., Morra F., Celetti A. A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options. Exploration of Targeted Anti-tumor Therapy . 2022;3(5):570&#x2013;581. doi: 10.37349/etat.2022.00101.</Citation><ArticleIdList><ArticleId IdType="doi">10.37349/etat.2022.00101</ArticleId><ArticleId IdType="pmc">PMC9630094</ArticleId><ArticleId IdType="pubmed">36338517</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M. R., Zhu W. T., Pei D. S. System xc(-): a key regulatory target of ferroptosis in cancer. Investigational New Drugs . 2021;39(4):1123&#x2013;1131. doi: 10.1007/s10637-021-01070-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10637-021-01070-0</ArticleId><ArticleId IdType="pubmed">33506324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Lin Z., Liu L., et al. Fe2+/Fe3+Ions chelated with ultrasmall polydopamine nanoparticles induce ferroptosis for cancer therapy. ACS Biomaterials Science &amp; Engineering . 2019;5(9):4861&#x2013;4869. doi: 10.1021/acsbiomaterials.9b00461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsbiomaterials.9b00461</ArticleId><ArticleId IdType="pubmed">33448829</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai T., Iwata S., Hirayama T., et al. Intracellular Fe2+ accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage. Scientific Reports . 2019;9(1):p. 6228. doi: 10.1038/s41598-019-42370-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-42370-z</ArticleId><ArticleId IdType="pmc">PMC6470176</ArticleId><ArticleId IdType="pubmed">30996325</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao J., Bai Z., Zhang L., Zhang F. Ferrostatin-1 alleviates tissue and cell damage in diabetic retinopathy by improving the antioxidant capacity of the Xc&#x2212;-GPX4 system. Cell Death Discovery . 2022;8(1):p. 426. doi: 10.1038/s41420-022-01141-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-022-01141-y</ArticleId><ArticleId IdType="pmc">PMC9596714</ArticleId><ArticleId IdType="pubmed">36284090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang J., Liu X., Yang Y., Zhang Y., Guan G. Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: conventional drug in new use. Journal of Cellular and Molecular Medicine . 2021;25(12):5372&#x2013;5380. doi: 10.1111/jcmm.16548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16548</ArticleId><ArticleId IdType="pmc">PMC8184680</ArticleId><ArticleId IdType="pubmed">33988296</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller T., Dewitz C., Schmitz J., et al. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure. Cellular and Molecular Life Sciences . 2017;74(19):3631&#x2013;3645. doi: 10.1007/s00018-017-2547-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2547-4</ArticleId><ArticleId IdType="pmc">PMC5589788</ArticleId><ArticleId IdType="pubmed">28551825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber R., Buchholz B., Kraus A., et al. Lipid peroxidation drives renal cyst growth in vitro through activation of TMEM16A. Journal of the American Society of Nephrology . 2019;30(2):228&#x2013;242. doi: 10.1681/ASN.2018010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2018010039</ArticleId><ArticleId IdType="pmc">PMC6362630</ArticleId><ArticleId IdType="pubmed">30606785</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S., Xiao X. Ferroptosis and kidney diseases. International Urology and Nephrology . 2020;52(3):497&#x2013;503. doi: 10.1007/s11255-019-02335-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-019-02335-7</ArticleId><ArticleId IdType="pubmed">31768804</ArticleId></ArticleIdList></Reference><Reference><Citation>Miess H., Dankworth B., Gouw A. M., et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene . 2018;37(40):5435&#x2013;5450. doi: 10.1038/s41388-018-0315-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-018-0315-z</ArticleId><ArticleId IdType="pmc">PMC6173300</ArticleId><ArticleId IdType="pubmed">29872221</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Liu J., He J., et al. UBIAD1 alleviates ferroptotic neuronal death by enhancing antioxidative capacity by cooperatively restoring impaired mitochondria and Golgi apparatus upon cerebral ischemic/reperfusion insult. Cell &amp; Bioscience . 2022;12(1):p. 42. doi: 10.1186/s13578-022-00776-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00776-9</ArticleId><ArticleId IdType="pmc">PMC8981649</ArticleId><ArticleId IdType="pubmed">35379328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Zheng L., Shang W., et al. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death and Differentiation . 2022;29(11):2190&#x2013;2202. doi: 10.1038/s41418-022-01008-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-01008-w</ArticleId><ArticleId IdType="pmc">PMC9613693</ArticleId><ArticleId IdType="pubmed">35534546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Guo J., Yu N., et al. Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model. Life Sciences . 2020;261, article 118487 doi: 10.1016/j.lfs.2020.118487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118487</ArticleId><ArticleId IdType="pubmed">32979361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G., Sui S., Shi F., Wang Q. Inhibition of USP14 suppresses ferroptosis and inflammation in LPS-induced goat mammary epithelial cells through ubiquitylating the IL-6 protein. Hereditas . 2022;159(1):p. 21. doi: 10.1186/s41065-022-00235-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41065-022-00235-y</ArticleId><ArticleId IdType="pmc">PMC9102600</ArticleId><ArticleId IdType="pubmed">35549778</ArticleId></ArticleIdList></Reference><Reference><Citation>Han F., Li S., Yang Y., Bai Z. Interleukin-6 promotes ferroptosis in bronchial epithelial cells by inducing reactive oxygen species-dependent lipid peroxidation and disrupting iron homeostasis. Bioengineered . 2021;12(1):5279&#x2013;5288. doi: 10.1080/21655979.2021.1964158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21655979.2021.1964158</ArticleId><ArticleId IdType="pmc">PMC8806540</ArticleId><ArticleId IdType="pubmed">34402724</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Jiang M., Li K., et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nature Immunology . 2021;22(9):1107&#x2013;1117. doi: 10.1038/s41590-021-00993-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00993-3</ArticleId><ArticleId IdType="pmc">PMC8609402</ArticleId><ArticleId IdType="pubmed">34385713</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood N. E., Barral P., Batista F. D. Neutrophils&#x2014;the unexpected helpers of B&#x2010;cell activation. EMBO Reports . 2012;13(2):93&#x2013;94. doi: 10.1038/embor.2011.259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/embor.2011.259</ArticleId><ArticleId IdType="pmc">PMC3271345</ArticleId><ArticleId IdType="pubmed">22240972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly S., Nedosekin D., Wong H. K. Review of an anti-CD20 monoclonal antibody for the treatment of autoimmune diseases of the skin. American Journal of Clinical Dermatology . 2023;24(2):247&#x2013;273. doi: 10.1007/s40257-022-00751-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40257-022-00751-7</ArticleId><ArticleId IdType="pmc">PMC9838371</ArticleId><ArticleId IdType="pubmed">36630066</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford H. F., Haljasm&#xe4;gi L., Menon M., et al. Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFN&#x3b1; and B cell subsets. Cell Reports Medicine . 2023;4(1, article 100894) doi: 10.1016/j.xcrm.2022.100894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100894</ArticleId><ArticleId IdType="pmc">PMC9873953</ArticleId><ArticleId IdType="pubmed">36652906</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>